NCT06440993
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06440993
Title Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Uniklinik RWTH Aachen RECRUITING Aachen Germany Details
Universitätsklinikum Bonn RECRUITING Bonn Germany Details
Universitätsklinikum Köln RECRUITING Cologne Germany Details
Universitätsklinikum Düsseldorf RECRUITING Düsseldorf Germany Details
Krankenhaus Nordwest RECRUITING Frankfurt 60488 Germany Details
Universitätsmedizin Göttingen RECRUITING Göttingen Germany Details
Medizinische Hochschule Hannover RECRUITING Hanover Germany Details
UKSH Campus Lübeck RECRUITING Lübeck Germany Details
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz RECRUITING Mainz Germany Details
Universitätsklinik Münster NOT_YET_RECRUITING Münster Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field